Brevan Howard Capital Management’s Erasca ERAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$892K Buy
55,104
+2,373
+5% +$28K 0.01% 969
2025
Q4
$196K Sell
52,731
-38,015
-42% -$107K ﹤0.01% 1585
2025
Q3
$198K Sell
90,746
-31,925
-26% -$50.8K ﹤0.01% 1757
2025
Q2
$156K Buy
+122,671
New +$164K ﹤0.01% 1753
2025
Q1
Sell
-16,158
Closed -$40.6K 1250
2024
Q4
$40.6K Buy
+16,158
New +$44.3K ﹤0.01% 990
2024
Q2
Sell
-18,638
Closed -$38.4K 1144
2024
Q1
$38.4K Buy
+18,638
New +$37.3K ﹤0.01% 949

Other funds holding ERAS

Brevan Howard Capital Management's ERAS Position: Q1 2026 in Review

Brevan Howard Capital Management increased its Erasca (ERAS) stake by 4.5% in Q1 2026, buying an estimated $28K and bringing the position to 55,104 shares worth $892K. The position accounts for 0.01% of the portfolio, ranked #969.

Brevan Howard Capital Management first reported a position in ERAS in Q1 2024 and has held it in 6 quarters since. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • Brevan Howard Capital Management held 55,104 shares of Erasca worth $892K as of Q1 2026.
  • Brevan Howard Capital Management bought 2,373 Erasca shares in Q1 2026, an estimated $28K.
  • Erasca made up 0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #969 holding.
  • Brevan Howard Capital Management first reported a position in Erasca in Q1 2024 and has held it in 6 quarters since.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.